Gauthier S. (2001). Cholinergic adverse effects of cholinesterase inhibitors in Alzheimer's disease: epidemiology and management, Drugs Aging, 18(11), 853-62.

Gauthier S., Ferris S. (2001). Outcome measures for probable vascular dementia and Alzheimer's disease with cerebrovascular disease, Int J Clin Pract Suppl(120), 29-39.

Gauthier S., Gauthier S., Dupin F., Panisset M. (2001). Comment déterminer l'aptitude du mandant? . Dans Formation permanente du Barreau du Québec, (Éd.) , Les mandats en cas d'inaptitude: une panacée? (pp. 71-82). Les Éditions Yvon Blais Inc..

Juaneda C., Dumont Y., Chabot J. G., Quirion R. (2001). Autoradiographic distribution of adrenomedullin receptors in the rat brain, Eur J Pharmacol, 421(2), R1-2.

Kibar Z., Underhill D. A., Canonne-Hergaux F., Gauthier S., Justice M. J., Gros P. (2001). Identification of a new chemically induced allele (Lp(m1Jus)) at the loop-tail locus: morphology, histology, and genetic mapping, Genomics, 72(3), 331-7.

Law A., Gauthier S., Quirion R. (2001). Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type, Brain Res Brain Res Rev, 35(1), 73-96.

Law A., Gauthier S., Quirion R. (2001). Neuroprotective and neurorescuing effects of isoform-specific nitric oxide synthase inhibitors, nitric oxide scavenger, and antioxidant against beta-amyloid toxicity, Br J Pharmacol, 133(7), 1114-24.

Lehmann D. J., Wiebusch H., Marshall S. E., Johnston C., Warden D. R., Morgan K., Schappert K., Poirier J., Xuereb J., Kalsheker N., Welsh K. I., Smith A. D. (2001). HLA class I, II & III genes in confirmed late-onset Alzheimer's disease, Neurobiol Aging, 22(1), 71-7.

Ma W., Quirion R. (2001). Increased phosphorylation of cyclic AMP response element-binding protein (CREB) in the superficial dorsal horn neurons following partial sciatic nerve ligation, Pain, 93(3), 295-301.

Ma W., Zheng W. H., Belanger S., Kar S., Quirion R. (2001). Effects of amyloid peptides on cell viability and expression of neuropeptides in cultured rat dorsal root ganglion neurons: a role for free radicals and protein kinase C, Eur J Neurosci, 13(6), 1125-35.

Ma W., Zheng W. H., Powell K., Jhamandas K., Quirion R. (2001). Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: an in vitro and in vivo study, Eur J Neurosci, 14(7), 1091-104.

Marcotte E. R., Srivastava L., Quirion R. (2001). DNA microarrays in neuropsychopharmacology, Trends Pharmacol Sci, 22(8), 426-36.

Mollereau C., Gouarderes C., Dumont Y., Kotani M., Detheux M., Doods H., Parmentier M., Quirion R., Zajac J. M. (2001). Agonist and antagonist activities on human NPFF(2) receptors of the NPY ligands GR231118 and BIBP3226, Br J Pharmacol, 133(1), 1-4.

Patterson C., Gauthier S. (2001). Canadian consensus conference on dementia: two years later, Can J Neurol Sci, 28 Suppl 1, S1-2.

Patterson C., Gauthier S., Bergman H., Cohen C., Feightner J. W., Feldman H., Grek A., Hogan D. B. (2001). The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia, Can J Neurol Sci, 28 Suppl 1, S3-16.

Petit-Turcotte C., Poirier J. (2001). Neurotransmitter in the Aging Brain . Dans Maddox G. L. (Éd.) , The encyclopedia of aging : a comprehensive resource in gerontology and geriatrics (pp. 343-346). Springer Publishing Co..

Petit-Turcotte C., Stohl S. M., Beffert U., Cohn J. S., Aumont N., Tremblay J., Dea D., Yang L., Poirier J., Shachter N. S. (2001). Apolipoprotein C-I expression in the brain in Alzheimer's disease, Neurobiol Dis, 8(6), 953-63.

Poirier J. (2001). Apolipoprotein E and Alzheimer's disease, Ann N Y Acad Sci, 972, 81-92.

Pruessner J., Collins D. L., Pruessner J., Evans A. C. (2001). Age and gender predict volume decline in the anterior and posterior hippocampus in early adulthood, J Neurosci, 21(1), 194-200.

Puma C., Danik M., Quirion R., Ramon F., Williams S. (2001). The chemokine interleukin-8 acutely reduces Ca(2+) currents in identified cholinergic septal neurons expressing CXCR1 and CXCR2 receptor mRNAs, J Neurochem, 78(5), 960-71.